MediFind
Condition

Bullous Pemphigoid

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 18
  • Start Date: March 11, 2020
Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 300
  • Start Date: February 1, 2020
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: January 30, 2020
Double-Blind, Randomized, Placebo-Controlled Trial of AKST4290 for Adjunctive Treatment of Mild to Moderate Bullous Pemphigoid
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 9
  • Start Date: September 25, 2018
A Phase IIa Open-label Single Arm Study of Safety and Efficacy of rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 12
  • Start Date: September 6, 2017
Topical Infliximab for the Treatment of Sterile Corneal Melt
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 150
  • Start Date: April 2016
Prevalence and Clinical Severity of Autoimmune Blistering Diseases
Clinical Trial
Other
  • Status: Active, not recruiting
  • Participants: 113
  • Start Date: April 1, 2009
The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors: Α Ten-year Prospective Observational Study.